LegendaryProfit wrote: That's correct. According to the release i pasted below, it's two seperate facilities. One for the reagents and THR for cannabis production and finished goods manufacturing (this would mean that the actual APP process is done at the THR facility which is licensed for it at the moment.) If they sell THR, they can easily leverage LP facilities which are already licensed and all they have to do is provide the reagents from their current facility and set up the APP process with the LP or other CPG company.
ANCOUVER, BC, SEPTEMBER 19, 2019– Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) is pleased to announce an expansion of its operations with a new manufacturing facility in close proximity to the Toronto Herbal Remedies Inc. (“THR”) (the Company’s wholly-owned licensed cannabis producer) production facility in Scarborough, Ontario. The additional property allows the Company to continue to centralize operations in the Greater Toronto Area, as well as providing manufacturing capabilities for it’s proprietary reagents, a key input for the APP Technology cannabinoid recovery process.
As Sproutly continues to explore other global markets for expansion, the need to produce it’s proprietary reagents at one central location and under EU GMP guidelines will be critical to ensuring consistency and quality, while at the same time reducing manufacturing costs. The new facility will also ensure that all space at THR is allocated to cannabis production and finished goods manufacturing.
The additional facility will not need to be licensed by Health Canada as no cannabis or cannabis products will be present on site.